Page 3 - Drug Class Review
P. 3
Final Report Update 1 Drug Effectiveness Review Project
Appendix D. Characteristics of Excluded Studies ...............................................................................201
Appendix E. Abstract-only Studies (not included) ...............................................................................202
Appendix F. Acknowledgements .........................................................................................................205
Suggested citation for this report:
Hansen RA, Gartlehner G, Kaufer D, Lohr K, Carey T. Drug Class Review of Alzheimer’s
Drugs. Final Report. 2006 http://www.ohsu.edu/drugeffectiveness/reports/final.cfm
Funding:
The funding source, the Center for Evidence-based Policy, is supported by 17 organizations, including 15
state Medicaid programs. These organizations selected the topic and had input into the Key Questions
for this review. The content and conclusions of the review are entirely determined by the Evidence-based
Practice Center researchers. The authors of this report have no financial interest in any company that
makes or distributes the products reviewed in this report.
Alzheimer's Drugs Page 3 of 205
